Tag: Abbott

Abbott Scientists Identified New Subtype of Human Immunodeficiency Virus

Abbott announced that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Group M, subtype L. The findings, published in the Journal of Acquired I...

Abbott and Omada Health Partnering to Integrate FreeStyle Libre System

abbott
Abbott and Omada Health announced they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring (CGM) technology, with Omada Health's pioneering digit...

FDA Approved Abbott’s Proclaim XR™ Recharge-Free Neurostimulation System

abbott
Abbott announced the U.S. Food and Drug Administration (FDA) has approved the company's Proclaim XR™ recharge-free neurostimulation system for people living with chronic pain. The Proclaim XR platf...

Abbott Announced European Approvals for Two Life-Saving Pediatric Devices

abbott
Abbott announced approvals in Europe for two of its life-saving pediatric devices. The Masters HP™ 15mm rotatable mechanical heart valve and the Amplatzer Piccolo™ Occluder have received CE Mark and a...

Abbott Received Public Reimbursement in Ontario and Quebec for FreeStyle® Libre System

abbott
Abbott, the global leader in sensor-based glucose monitoring, announced that it has received public reimbursement in Ontario and Quebec for its FreeStyle® Libre system, becoming the first sensor-based...

Sanofi & Abbott Agreed to Integrate Glucose Sensing and Insulin Delivery Technologies

insulin syringe
Sanofi and Abbott are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition. The two companies w...

Abbott Launched Pivotal Test of New Approach for Repairing Leaky Tricuspid Heart Valves

Abbott announced the launch of the company's TRILUMINATE Pivotal trial to evaluate the safety and effectiveness of the company's TriClip transcatheter tricuspid valve repair system for the treatment o...

Abbott Granted Intoximeters Rights to Market Abbott’s SoToxaTM Mobile Test System

abbott
Abbott and Intoximeters announced an agreement for Intoximeters to market Abbott's SoToxaTM Mobile Test System – a handheld oral fluid roadside testing solution that rapidly and reliably detects recen...

FDA Approved New Blood and Plasma Screening Alinity™ s System

abbott
Abbott announced U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System. This new solution will bring the latest screening technology to U.S. blood a...

Abbott to Start Making Syringes, Nasal Drops in Vladimir Region

The U.S. pharmaceutical company Abbott which owns a 100% stake in Veropharm, and the Vladimir regional administration have signed a memorandum of cooperation. The agreement was signed on the sideli...

Abbott Launched Test To Detect Diabetes

blood-sugar
Abbott announced that its Afinion™ HbA1c Dx assay is now available for use on the Afinion 2 Analyzer, as well as the Afinion AS100 Analyzer. The Afinion HbA1c Dx assay is the first and only rapid poin...

Abbott Announced New Data on Continuous Glucose Monitoring Technology

Abbott announced new data showing use of its FreeStyle Libre system, the company's revolutionary continuous glucose monitoring (CGM) technology, significantly reduced hemoglobin A1c (HbA1c) levels for...

Abbott to Cooperate with NIH on Brain Initiative

neuronet
Abbott today announced that it has partnered with the National Institutes of Health on the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative to accelerate advancements i...

World’s First Point-of-Care HIV Test Received WHO PQ Approval

Abbott announced that m-PIMA™ HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, has received the World Health Organization's Prequalification approval (WHO PQ). The test received...

Abbott Announced CE Mark for its Diagnostics System

Alinity m will allow labs to meet the growing demand for infectious disease testing by offering increased efficiency and market-leading speed and accuracy. Abbott announced today CE Mark for its Al...

FDA Expanded Approval for Abbott’s MitraClip™ Device

The world's first minimally invasive mitral valve repair device now approved to help difficult-to-treat heart failure patients with clinically significant secondary mitral regurgitation. Abbott ann...